Simeon George Insider Trading $CRSP CRISPR Therapeutics AG
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Simeon George.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Simeon George. Simeon George is Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Principia Biopharma Inc. ($PRNB) and Director in Turning Point Therapeutics, Inc. ($TPTX) and Director in CRISPR Therapeutics AG ($CRSP) and Director in Nkarta, Inc. ($NKTX) and Director in Design Therapeutics, Inc. ($DSGN).
Simeon George in CRISPR Therapeutics AG
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Simeon George: Director
Holdings: 2,942,560 shares
Current Value: $46,345,320
Latest Transaction: Jun 15 2020
$CRSP Market Capitalization: $605.88M
$CRSP Previous Close: $15.75
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Simeon George in CRISPR Therapeutics AG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRSP, DSGN, GNCA, NKTX, PRNB, TPTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15 2020 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 59.70 | 15,000 | 895,500 | 15,000 | |
| Jun 13 2019 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 43.52 | 15,000 | 652,800 | 15,000 | |
| Jun 19 2018 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
| Jun 02 2017 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 13.62 | 15,000 | 204,300 | 15,000 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 211,567 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | C | 0.00 | 2,942,560 | 0 | 0 | |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | P | 14.00 | 66,500 | 931,000 | 3,220,627 | 3.2 M to 3.2 M (+2.11 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 211,567 | 0 | 3,154,127 | 2.9 M to 3.2 M (+7.19 %) |
| Oct 26 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Buy | C | 0.00 | 2,942,560 | 0 | 2,942,560 | 0 to 2.9 M |
| Oct 20 2016 | CRSP | CRISPR Therapeutic ... | George Simeon | Director | Option Exercise | A | 14.00 | 30,000 | 420,000 | 30,000 |
Page: 1